Cresco Labs Inc (CRLBF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 724,343 | 770,885 | 842,681 | 821,682 | 476,251 |
| Cost of Goods | 359,889 | 408,519 | 435,668 | 415,335 | 269,550 |
| Gross Profit | 364,454 | 362,366 | 407,013 | 406,347 | 206,701 |
| Operating Expenses | 258,051 | 450,708 | 491,976 | 624,033 | 230,713 |
| Operating Income | 107,292 | -87,823 | -84,295 | -217,351 | -23,462 |
| Interest Expense | 55,979 | 60,819 | 57,837 | 51,211 | 31,229 |
| Other Income | -61,929 | 1,740 | 15,227 | 11,835 | -9,476 |
| Pre-tax Income | -10,616 | -146,902 | -126,905 | -256,727 | -64,167 |
| Income Tax | 49,873 | 32,950 | 88,938 | 40,107 | 28,604 |
| Net Income Continuous | -60,489 | -179,852 | -215,843 | -296,834 | -92,771 |
| Minority Interests | 13,949 | -4,330 | -3,796 | 22,763 | 9,386 |
| Net Income | $-74,438 | $-175,522 | $-212,047 | $-319,597 | $-102,157 |
| EPS Basic Total Ops | -0.22 | -0.54 | -0.71 | -1.22 | -0.49 |
| EPS Basic Continuous Ops | -0.18 | -0.56 | -0.72 | -1.13 | -0.44 |
| EPS Diluted Total Ops | -0.22 | -0.54 | -0.71 | -1.22 | -0.49 |
| EPS Diluted Continuous Ops | -0.18 | -0.56 | -0.72 | -1.13 | -0.44 |
| EPS Diluted Before Non-Recurring Items | -0.22 | -0.17 | -0.20 | -0.05 | -0.39 |
| EBITDA(a) | $173,285 | $-18,519 | $-26,570 | $-172,402 | $13,293 |